Entries of Reifenberger, Guido on the publication server
![]() | Up a level |
Number of items: 39.
2023
Hertler, Caroline, Felsberg, Jörg, Gramatzki, Dorothee
, Le Rhun, Emilie, Clarke, Jennifer
, Soffietti, Riccardo, Wick, Wolfgang
, Chinot, Olivier, Ducray, François, Roth, Patrick, McDonald, Kerrie, Hau, Peter, Hottinger, Andreas F., Reijneveld, Jaap, Schnell, Oliver, Marosi, Christine, Glantz, Michael, Darlix, Amélie, Lombardi, Giuseppe, Krex, Dietmar, Glas, Martin, Reardon, David A., van den Bent, Martin
, Lefranc, Florence, Herrlinger, Ulrich, Razis, Evangelia, Carpentier, Antoine F., Phillips, Samuel, Rudà, Roberta, Wick, Antje
, Tabouret, Emeline, Meyronet, David, Maurage, Claude-Alain, Rushing, Elisabeth, Rapkins, Robert, Bumes, Elisabeth, Hegi, Monika, Weyerbrock, Astrid, Aregawi, Dawit, Gonzalez-Gomez, Christian, Pellerino, Alessia
, Klein, Martin, Preusser, Matthias
, Bendszus, Martin, Golfinopoulos, Vassilis, von Deimling, Andreas, Gorlia, Thierry, Wen, Patrick Y., Reifenberger, Guido and Weller, Michael
(2023)
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419).
European Journal of Cancer 189, p. 112913.
Fulltext not available.
, Le Rhun, Emilie, Clarke, Jennifer
, Soffietti, Riccardo, Wick, Wolfgang
, Chinot, Olivier, Ducray, François, Roth, Patrick, McDonald, Kerrie, Hau, Peter, Hottinger, Andreas F., Reijneveld, Jaap, Schnell, Oliver, Marosi, Christine, Glantz, Michael, Darlix, Amélie, Lombardi, Giuseppe, Krex, Dietmar, Glas, Martin, Reardon, David A., van den Bent, Martin
, Lefranc, Florence, Herrlinger, Ulrich, Razis, Evangelia, Carpentier, Antoine F., Phillips, Samuel, Rudà, Roberta, Wick, Antje
, Tabouret, Emeline, Meyronet, David, Maurage, Claude-Alain, Rushing, Elisabeth, Rapkins, Robert, Bumes, Elisabeth, Hegi, Monika, Weyerbrock, Astrid, Aregawi, Dawit, Gonzalez-Gomez, Christian, Pellerino, Alessia
, Klein, Martin, Preusser, Matthias
, Bendszus, Martin, Golfinopoulos, Vassilis, von Deimling, Andreas, Gorlia, Thierry, Wen, Patrick Y., Reifenberger, Guido and Weller, Michael
(2023)
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419).
European Journal of Cancer 189, p. 112913.
Fulltext not available.
Pohl, Sandra, Dimitrova, Lora, Grassow-Narlik, Maja, Jöhrens, Korinna, Acker, Till, Dohmen, Hildegard, Herms, Jochen, Dorostkar, Mario, Hartmann, Christian, Hasselblatt, Martin, Neumann, Manuela
, Reifenberger, Guido, Felsberg, Jörg, Schüller, Ulrich, Zoubaa, Saida, Lorenz, Julia, Rothhammer-Hampl, Tanja, Mauch-Mücke, Katrin and Riemenschneider, Markus J.
(2023)
Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021.
Clinical Neuropathology 42 (05), pp. 112-121.
Fulltext not available.
, Reifenberger, Guido, Felsberg, Jörg, Schüller, Ulrich, Zoubaa, Saida, Lorenz, Julia, Rothhammer-Hampl, Tanja, Mauch-Mücke, Katrin and Riemenschneider, Markus J.
(2023)
Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021.
Clinical Neuropathology 42 (05), pp. 112-121.
Fulltext not available.
2021
Rothhammer-Hampl, Tanja, Liesenberg, Franziska, Hansen, Natalie, Hoja, Sabine, Delic, Sabit, Reifenberger, Guido and Riemenschneider, Markus J.
(2021)
Frequent Epigenetic Inactivation of DIRAS-1 and DIRAS-2 Contributes to Chemo-Resistance in Gliomas.
Cancers 13 (20), pp. 1-17.
Tzaridis, Theophilos
, Schäfer, Niklas, Weller, Johannes, Steinbach, Joachim‐Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Jörg‐Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich and Felsberg, Jörg
(2021)
MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial.
International Journal of Cancer 148 (7), pp. 1695-1707.
Fulltext not available.
, Schäfer, Niklas, Weller, Johannes, Steinbach, Joachim‐Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Jörg‐Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich and Felsberg, Jörg
(2021)
MGMT promoter methylation analysis for allocating combined CCNU / TMZ chemotherapy: Lessons learned from the CeTeG / NOA ‐09 trial.
International Journal of Cancer 148 (7), pp. 1695-1707.
Fulltext not available.
2020
Riemenschneider, Markus J.
, Fischer, Josephine, Grassow-Narlik, Maja, Mawrin, Christian, von Deimling, Andreas
, Pietsch, Torsten, Reifenberger, Guido, Mueller, Wolf C., Sommer, Clemens J., Dietel, Manfred, Zoubaa, Saida, Lorenz, Julia and Rothhammer-Hampl, Tanja
(2020)
Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019.
Clinical Neuropathology 39 (09), pp. 203-211.
Fulltext not available.
, Fischer, Josephine, Grassow-Narlik, Maja, Mawrin, Christian, von Deimling, Andreas
, Pietsch, Torsten, Reifenberger, Guido, Mueller, Wolf C., Sommer, Clemens J., Dietel, Manfred, Zoubaa, Saida, Lorenz, Julia and Rothhammer-Hampl, Tanja
(2020)
Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019.
Clinical Neuropathology 39 (09), pp. 203-211.
Fulltext not available.
2019
Wirthschaft, Peter, Bode, Julia, Soni, Himanshu, Dietrich, Fabio, Krüwel, Thomas, Fischer, Bernd, Knobbe-Thomsen, Christiane B., Rossetti, Giulia
, Hentschel, Andreas, Mack, Norman, Schönig, Kai, Breckwoldt, Michael O., Schmandke, André, Pusch, Stefan, Medenbach, Jan
, Bendszus, Martin, Schwab, Martin E., von Deimling, Andreas
, Kool, Marcel, Herold-Mende, Christel, Reifenberger, Guido, Ahrends, Robert and Tews, Björn
(2019)
RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas.
Acta Neuropathologica 138 (2), pp. 275-293.
Fulltext not available.
, Hentschel, Andreas, Mack, Norman, Schönig, Kai, Breckwoldt, Michael O., Schmandke, André, Pusch, Stefan, Medenbach, Jan
, Bendszus, Martin, Schwab, Martin E., von Deimling, Andreas
, Kool, Marcel, Herold-Mende, Christel, Reifenberger, Guido, Ahrends, Robert and Tews, Björn
(2019)
RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomas.
Acta Neuropathologica 138 (2), pp. 275-293.
Fulltext not available.
2016
Suchorska, Bogdana, Weller, Michael, Tabatabai, Ghazaleh, Senft, Christian
, Hau, Peter, Sabel, Michael C., Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe, Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Jörg C. and Wirsching, Hans-Georg
(2016)
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial.
Neuro-Oncology 18 (4), pp. 549-556.
Fulltext not available.
, Hau, Peter, Sabel, Michael C., Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe, Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Jörg C. and Wirsching, Hans-Georg
(2016)
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial.
Neuro-Oncology 18 (4), pp. 549-556.
Fulltext not available.
Codó, Paula, Weller, Michael, Kaulich, Kerstin, Schraivogel, Daniel
, Silginer, Manuela, Reifenberger, Guido, Meister, Gunter and Roth, Patrick
(2016)
Control of glioma cell migration and invasiveness by GDF-15.
Oncotarget 7 (7).
Fulltext not available.
, Silginer, Manuela, Reifenberger, Guido, Meister, Gunter and Roth, Patrick
(2016)
Control of glioma cell migration and invasiveness by GDF-15.
Oncotarget 7 (7).
Fulltext not available.
Wick, Wolfgang, Roth, Patrick
, Hartmann, Christian, Hau, Peter, Nakamura, Makoto, Stockhammer, Florian
, Sabel, Michael C., Wick, Antje, Koeppen, Susanne, Ketter, Ralf, Vajkoczy, Peter, Eyupoglu, Ilker, Kalff, Rolf, Happold, Caroline, Galldiks, Norbert, Schmidt-Graf, Friederike, Bamberg, Michael, Reifenberger, Guido, Platten, Michael, von Deimling, Andreas
, Meisner, Christoph
, Wiestler, Benedikt and Weller, Michael
(2016)
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Neuro-Oncology, now133.
Fulltext not available.
, Hartmann, Christian, Hau, Peter, Nakamura, Makoto, Stockhammer, Florian
, Sabel, Michael C., Wick, Antje, Koeppen, Susanne, Ketter, Ralf, Vajkoczy, Peter, Eyupoglu, Ilker, Kalff, Rolf, Happold, Caroline, Galldiks, Norbert, Schmidt-Graf, Friederike, Bamberg, Michael, Reifenberger, Guido, Platten, Michael, von Deimling, Andreas
, Meisner, Christoph
, Wiestler, Benedikt and Weller, Michael
(2016)
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Neuro-Oncology, now133.
Fulltext not available.
Schliesser, Maximilian Georg, Claus, Rainer, Hielscher, Thomas, Grimm, Christiane, Weichenhan, Dieter, Blaes, Jonas, Wiestler, Benedikt, Hau, Peter, Schramm, Johannes, Sahm, Felix, Weiß, Elisa K., Weiler, Markus, Baer, Constance, Schmidt-Graf, Friederike, Schackert, Gabriele, Westphal, Manfred, Hertenstein, Anne, Roth, Patrick
, Galldiks, Norbert, Hartmann, Christian, Pietsch, Torsten, Felsberg, Jörg, Reifenberger, Guido, Sabel, Michael Christoph, Winkler, Frank, von Deimling, Andreas
, Meisner, Christoph, Vajkoczy, Peter, Platten, Michael
, Weller, Michael, Plass, Christoph and Wick, Wolfgang
(2016)
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Oncotarget 7 (50).
Fulltext not available.
, Galldiks, Norbert, Hartmann, Christian, Pietsch, Torsten, Felsberg, Jörg, Reifenberger, Guido, Sabel, Michael Christoph, Winkler, Frank, von Deimling, Andreas
, Meisner, Christoph, Vajkoczy, Peter, Platten, Michael
, Weller, Michael, Plass, Christoph and Wick, Wolfgang
(2016)
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Oncotarget 7 (50).
Fulltext not available.
2015
Weller, Michael, Tabatabai, Ghazaleh, Kästner, Bärbel, Felsberg, Jörg, Steinbach, Joachim P., Wick, Antje, Schnell, Oliver, Hau, Peter, Herrlinger, Ulrich, Sabel, Michael C., Wirsching, Hans-Georg, Ketter, Ralf, Bähr, Oliver, Platten, Michael
, Tonn, Jörg C., Schlegel, Uwe, Marosi, Christine, Goldbrunner, Roland, Stupp, Roger, Homicsko, Krisztian, Pichler, Josef, Nikkhah, Guido, Meixensberger, Jürgen, Vajkoczy, Peter, Kollias, Spyros, Hüsing, Johannes, Reifenberger, Guido and Wick, Wolfgang
(2015)
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.
Clinical Cancer Research 21 (9), pp. 2057-2064.
Fulltext not available.
, Tonn, Jörg C., Schlegel, Uwe, Marosi, Christine, Goldbrunner, Roland, Stupp, Roger, Homicsko, Krisztian, Pichler, Josef, Nikkhah, Guido, Meixensberger, Jürgen, Vajkoczy, Peter, Kollias, Spyros, Hüsing, Johannes, Reifenberger, Guido and Wick, Wolfgang
(2015)
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.
Clinical Cancer Research 21 (9), pp. 2057-2064.
Fulltext not available.
Galldiks, Norbert
, Dunkl, Veronika, Stoffels, Gabriele
, Hutterer, Markus, Rapp, Marion, Sabel, Michael, Reifenberger, Guido, Kebir, Sied, Dorn, Franziska, Blau, Tobias, Herrlinger, Ulrich, Hau, Peter, Ruge, Maximilian I., Kocher, Martin, Goldbrunner, Roland, Fink, Gereon R.
, Drzezga, Alexander, Schmidt, Matthias and Langen, Karl-Josef
(2015)
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET.
European Journal of Nuclear Medicine and Molecular Imaging 42 (5), pp. 685-695.
Fulltext not available.
, Dunkl, Veronika, Stoffels, Gabriele
, Hutterer, Markus, Rapp, Marion, Sabel, Michael, Reifenberger, Guido, Kebir, Sied, Dorn, Franziska, Blau, Tobias, Herrlinger, Ulrich, Hau, Peter, Ruge, Maximilian I., Kocher, Martin, Goldbrunner, Roland, Fink, Gereon R.
, Drzezga, Alexander, Schmidt, Matthias and Langen, Karl-Josef
(2015)
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET.
European Journal of Nuclear Medicine and Molecular Imaging 42 (5), pp. 685-695.
Fulltext not available.
Suchorska, Bogdana, Weller, Michael, Tabatabai, Ghazaleh, Senft, Christian
, Hau, Peter, Sabel, Michael, Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe S., Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Joerg and Wirsching, Hans-Georg
(2015)
Does extent of resection matter in recurrent glioblastoma? Lessons from the DIRECTOR trial.
Journal of Clinical Oncology 33 (15_sup), p. 2041.
Fulltext not available.
, Hau, Peter, Sabel, Michael, Herrlinger, Ulrich, Ketter, Ralf, Schlegel, Uwe S., Marosi, Christine, Reifenberger, Guido, Wick, Wolfgang, Tonn, Joerg and Wirsching, Hans-Georg
(2015)
Does extent of resection matter in recurrent glioblastoma? Lessons from the DIRECTOR trial.
Journal of Clinical Oncology 33 (15_sup), p. 2041.
Fulltext not available.
2014
Delic, Sabit, Lottmann, Nadine, Stelzl, Anja, Liesenberg, Franziska, Wolter, Marietta, Götze, Silke, Zapatka, Marc, Shiio, Yuzuru, Sabel, Michael C., Felsberg, Jörg, Reifenberger, Guido and Riemenschneider, Markus J.
(2014)
MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
Neuro-Oncology 16 (2), pp. 179-190.
Fulltext not available.
Codo, Paula, Weller, Michael, Meister, Gunter, Szabo, Emese, Steinle, Alexander, Wolter, Marietta, Reifenberger, Guido and Roth, Patrick
(2014)
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.
Oncotarget 5 (17), pp. 7651-7662.
Fulltext not available.
(2014)
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.
Oncotarget 5 (17), pp. 7651-7662.
Fulltext not available.
2012
Schmidt, Natalie, Windmann, Sonja, Reifenberger, Guido and Riemenschneider, Markus J.
(2012)
DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas.
Brain pathology 22 (1), pp. 17-25.
Fulltext not available.
Wick, Wolfgang, Platten, Michael, Meisner, Christoph, Felsberg, Jörg, Tabatabai, Ghazaleh, Simon, Matthias, Nikkhah, Guido, Papsdorf, Kirsten, Steinbach, Joachim P., Sabel, Michael, Combs, Stephanie E., Vesper, Jan, Braun, Christian, Meixensberger, Jürgen, Ketter, Ralf, Mayer-Steinacker, Regine, Reifenberger, Guido and Weller, Michael
(2012)
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.
The lancet oncology 13 (7), pp. 707-715.
Fulltext not available.
2011
Lindemann, Carina, Hackmann, Oliver, Delic, Sabit, Schmidt, Natalie, Reifenberger, Guido and Riemenschneider, Markus J.
(2011)
SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation.
Acta neuropathologica 122 (2), pp. 241-251.
Fulltext not available.
Malzkorn, Bastian, Wolter, Marietta, Riemenschneider, Markus J. and Reifenberger, Guido
(2011)
Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets.
Brain pathology 21 (6), pp. 619-632.
Fulltext not available.
2010
Grzendowski, Michael, Wolter, Marietta, Riemenschneider, Markus J., Knobbe, Christiane B., Schlegel, Uwe, Meyer, Helmut E., Reifenberger, Guido and Stühler, Kai
(2010)
Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q.
Neuro-oncology 12 (3), pp. 243-256.
Fulltext not available.
Barski, Dimitri, Wolter, Marietta, Reifenberger, Guido and Riemenschneider, Markus J.
(2010)
Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas.
Brain pathology 20 (3), pp. 623-631.
Fulltext not available.
Riemenschneider, Markus J., Hegi, Monika E. and Reifenberger, Guido
(2010)
MGMT promoter methylation in malignant gliomas.
Targeted oncology 5 (3), pp. 161-165.
Fulltext not available.
Riemenschneider, Markus J., Jeuken, Judith W. M., Wesseling, Pieter and Reifenberger, Guido
(2010)
Molecular diagnostics of gliomas: state of the art.
Acta neuropathologica 120 (5), pp. 567-584.
Fulltext not available.
Riemenschneider, Markus J. and Reifenberger, Guido
(2010)
Molecular neuropathology of low-grade gliomas and its clinical impact.
In: Schramm, J., (ed.)
Low-Grade Gliomas.
Advances and Technical Standards in Neurosurgery, 35.
Springer, Wien, pp. 35-64.
ISBN 978-3-211-99480-1.
Fulltext not available.
2009
Riemenschneider, Markus J. and Reifenberger, Guido
(2009)
Astrocytic tumors.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 171, pp. 3-24.
Fulltext not available.
Rickert, Christian H., Riemenschneider, Markus J., Schachenmayr, Walter, Richter, Hans-Peter, Bockhorn, Jürgen, Reifenberger, Guido and Paulus, Werner
(2009)
Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.
Brain pathology 19 (3), pp. 431-438.
Fulltext not available.
Riemenschneider, Markus J. and Reifenberger, Guido
(2009)
Molecular neuropathology of gliomas.
International journal of molecular sciences 10 (1), pp. 184-212.
Fulltext not available.
Riemenschneider, Markus J. and Reifenberger, Guido
(2009)
Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches.
Current opinion in neurology 22 (6), pp. 619-624.
Fulltext not available.
Riemenschneider, Markus J., Beseoglu, Kerim, Hänggi, Daniel and Reifenberger, Guido
(2009)
Prostate adenocarcinoma metastasis in the pituitary gland.
Archives of neurology 66 (8), pp. 1036-1037.
Fulltext not available.
Scholz, Martin, Hoischen, Alexander, Radlwimmer, Bernhard, Weber, Ruthild G., Harders, Albrecht, Reifenberger, Guido and Riemenschneider, Markus J.
(2009)
Rosetted glioneuronal tumor of the spine with overtly anaplastic histological features.
Acta neuropathologica 117 (5), pp. 591-593.
Fulltext not available.
Grzendowski, Michael, Riemenschneider, Markus J., Hawranke, Eva, Stefanski, Anja, Meyer, Helmut E., Reifenberger, Guido and Stühler, Kai
(2009)
Simultaneous extraction of nucleic acids and proteins from tissue specimens by ultracentrifugation: A protocol using the high-salt protein fraction for quantitative proteome analysis.
Proteomics 9 (21), pp. 4985-4990.
Fulltext not available.
2008
Riemenschneider, Markus J., Reifenberger, Julia and Reifenberger, Guido
(2008)
Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss.
International journal of cancer. Journal international du cancer 122 (11), pp. 2503-2510.
Fulltext not available.
Tepel, Martin, Roerig, Peter, Wolter, Marietta, Gutmann, David H., Perry, Arie, Reifenberger, Guido and Riemenschneider, Markus J.
(2008)
Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
International journal of cancer. Journal international du cancer 123 (9), pp. 2080-2086.
Fulltext not available.
Beier, Dagmar, Röhrl, Stefanie, Pillai, Deepu R., Schwarz, Stefanie, Kunz-Schughart, Leoni A., Leukel, Petra, Proescholdt, Martin A., Brawanski, Alexander, Bogdahn, Ulrich, Trampe-Kieslich, Ariane, Giebel, Bernd, Wischhusen, Jörg, Reifenberger, Guido, Hau, Peter and Beier, Christoph P.
(2008)
Temozolomide preferentially depletes cancer stem cells in glioblastoma.
Cancer research 68 (14), pp. 5706-5715.
Fulltext not available.
2007
Floeth, Frank W., Pauleit, Dirk, Sabel, Michael, Stoffels, Gabriele, Reifenberger, Guido, Riemenschneider, Markus J., Jansen, Paul, Coenen, Heinz H., Steiger, Hans-Jakob and Langen, Karl-Josef
(2007)
Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.
Journal of nuclear medicine : official publication 48 (4), pp. 519-527.
Fulltext not available.
2006
Messing-Jünger, A. Martina, Riemenschneider, Markus J. and Reifenberger, Guido
(2006)
A 21-year-old female with a third ventricular tumor.
Brain pathology 16 (1), 87-88, 93.
Fulltext not available.
Riemenschneider, Markus J., Perry, Arie and Reifenberger, Guido
(2006)
Histological classification and molecular genetics of meningiomas.
Lancet neurology 5 (12), pp. 1045-1054.
Fulltext not available.
2005
Pauleit, Dirk, Floeth, Frank, Hamacher, Kurt, Riemenschneider, Markus J., Reifenberger, Guido, Müller, Hans-Wilhelm, Zilles, Karl, Coenen, Heinz H. and Langen, Karl-Josef
(2005)
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.
Brain : a journal of neurology 128 (Pt. 3), pp. 678-687.
Fulltext not available.
2004
Pauleit, Dirk, Langen, Karl-Josef, Floeth, Frank, Hautzel, Hubertus, Riemenschneider, Markus J., Reifenberger, Guido, Shah, N. Jon and Müller, Hans-Wilhelm
(2004)
Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?
Journal of magnetic resonance imaging : JMRI 20 (5), pp. 758-764.
Fulltext not available.
